Clinical Trials on Alcoholic Liver Cirrhosis

Total 15638 results

Perspectum
Children's Memorial Health Institute, Poland

Completed

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI (Kids4LIFe)

Liver Diseases | Autoimmune Hepatitis | Liver Cirrhoses | Non-alcoholic Steatohepatitis | Liver Fibroses

Poland
University of California, Los Angeles

Recruiting

Alcoholic Liver Disease and the Gut Microbiome

Alcohol Use Disorder | Alcoholic Liver Disease | Microbiome

United States
Abdelrahman Salah Eldin Abodief

Not yet recruiting

Assessing of Physicians' Knowledge About International Guidelines of Albumin Use in Patients With Liver Cirrhosis

Liver Cirrhoses
University Hospital, Bonn

Recruiting

Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis (NICETIES)

Liver Cirrhoses

Germany
Judit Pich

Completed

Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development (2018-001698-25)

Liver Cirrhoses

Belgium, Spain, United Kingdom, Italy, Netherlands, France, Germany
Institute of Liver and Biliary Sciences, India

Unknown

"To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt

Liver Cirrhoses

India
Instituto Nacional de Ciencias Medicas y Nutricion...

Unknown

Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

Liver Cirrhoses

Mexico
Seoul National University Hospital

Active, not recruiting

Preoperative Portal and Splanchnic Flow Measurement Using MRI

Liver Cirrhoses

Korea, Republic of
Institute of Liver and Biliary Sciences, India

Recruiting

Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)

Liver Cirrhoses

India
Institute of Liver and Biliary Sciences, India

Completed

Indirect Calorimeter Based Study in Patients With Liver Cirrhosis (METALIC)

Liver Cirrhoses

India
Dr.med. Monica Rusticeanu
University Hospital Inselspital, Berne; University of Bern

Terminated

Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC) (AMBIC)

Liver Cirrhoses

Switzerland
Judit Pich

Completed

Simvastatin Plus Rifaximin in Decompensated Cirrhosis (LIVERHOPE)

Cirrhoses, Liver

Spain, Germany, United Kingdom, Italy, Netherlands, France
Air Force Military Medical University, China

Recruiting

Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites

Liver Cirrhoses

China
Chuncheon Sacred Heart Hospital

Completed

Cognitive Function of Alcoholic Compensated Liver Cirrhosis

Alcoholic Liver Disease

Korea, Republic of
University Hospital, Caen
Thong DAO; Annie BOREL-DERLON; Nathalie GANNE-CARRIE; Pierre NAHON; Sylvie Chevret

Completed

Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis? (ABOCIRRALVIR)

Alcoholic or Viral C Compensated Cirrhosis

France
Centre Hospitalier Universitaire de Nīmes

Terminated

Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist (EchoCirrho)

Liver Cirrhoses

France
Institute of Liver and Biliary Sciences, India

Unknown

Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.

Liver Cirrhoses

India
Hunter Holmes Mcguire Veteran Affairs Medical Center
OpenBiome

Completed

Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis

Cirrhosis | Alcohol Abuse

United States
Centre Hospitalier Universitaire, Amiens

Withdrawn

Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence. (NalmeCir)

Alcohol Dependence | Cirrhosis | Nalmefene

France
Intercept Pharmaceuticals

Completed

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE)

Nonalcoholic Steatohepatitis | Compensated Cirrhosis

United States, Spain, France, Australia, New Zealand, Puerto Rico, Germany, Canada, United Kingdom, Hungary, Poland, Ukraine
NGM Biopharmaceuticals, Inc

Completed

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

Nonalcoholic Steatohepatitis | Compensated Cirrhosis

United States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
Sequana Medical N.V.

Recruiting

International Alfapump Cohort Study (TOPMOST)

Liver Cirrhoses | Malignant Ascites

Germany, Switzerland
Norgine

Completed

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Nonalcoholic Steatohepatitis | Hepatic Cirrhosis

Bulgaria
National Cancer Institute (NCI)

Completed

A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area

Hepatitis, Viral, Human | Carcinoma, Hepatocellular | Hepatitis, Chronic | Hepatitis, Alcoholic | Liver Cirrhosis, Alcoholic

United States
Fatty liver Foundation

Completed

A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations (SUNN)

Fatty Liver | NAFLD | NASH - Nonalcoholic Steatohepatitis | Cirrhosis, Liver

United States
Copenhagen University Hospital, Hvidovre
Aarhus University Hospital; Rigshospitalet, Denmark; University of Copenhagen

Terminated

Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis (STATLiver)

Liver Cirrhoses

Denmark
HaEmek Medical Center, Israel
Weizmann Institute of Science

Recruiting

Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.

Fibrosis, Liver | Cirrhosis, Liver | NAFLD - Nonalcoholic Fatty Liver Disease

Israel
Novartis Pharmaceuticals

Terminated

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. (ELIVATE)

Non Alcoholic Steatohepatitis (NASH)

United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more
Galecto Biotech AB
Covance

Withdrawn

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Non-alcoholic Steatohepatitis (NASH)
National Human Genome Research Institute (NHGRI)

Terminated

Genetic Studies of Non-Alcoholic Fatty Liver Disease

Liver Cirrhosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steato-Hepatitis

United States
Novartis Pharmaceuticals
Allergan

Completed

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis (TANDEM)

Non-alcoholic Steatohepatitis (NASH)

United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
Bristol-Myers Squibb

Completed

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis (FALCON 2)

Nonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD) | Hepatic Cirrhosis

United States, Japan
Postgraduate Institute of Medical Education and...

Unknown

Invasive Fungal Infections in Severe Alcohol-associated Hepatitis

Severe Alcoholic Hepatitis | Chronic Liver Disease and Cirrhosis

India
University Hospital for Infectious Diseases, Croatia
Croatian Science Foundation

Completed

The Role of Immune Semaphorins in NAFLD (SepsisFAT)

Immune Response | Biomarkers | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis

Croatia
E-Scopics
University Hospital, Bordeaux

Completed

Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation (DIACEPA)

Liver Diseases | Liver Cirrhosis | Non-Alcoholic Fatty Liver Disease

France
University of Palermo

Unknown

Effect on Liver Histology of Vitamin D in Patients With Non-alcoholic Steatohepatitis

Non.Alcoholic Fatty Liver Disease

Italy
Institute of Liver and Biliary Sciences, India

Completed

N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial

Liver Cirrhoses

India
Histogen

Completed

Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension (ENCORE-PH)

Cirrhosis | Portal Hypertension | Non-alcoholic Steatohepatitis

United States, Germany, Spain
Chuncheon Sacred Heart Hospital

Unknown

Effect of Probiotics on Gut-Liver Axis of Alcoholic Hepatitis

Alcoholic Liver Disease
University Clinic Dr Dragisa Misovic-Dedinje

Unknown

S-adenosylmethionine Plus Choline in Treatment of Patients With Alcoholic Liver Disease

Alcoholic Liver Diseases

Serbia
University Hospital, Angers

Completed

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study) (IMPROVE)

NAFLD | Liver Fibrosis | Alcohol-Related Disorder

France
Pfizer

Completed

Study in Healthy Adults Evaluating PF-07202954

Liver Fibrosis | Non-Alcoholic Fatty Liver Disease

United States
Rennes University Hospital

Completed

Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease (FibroMR)

Non-Alcoholic Fatty Liver Disease

France
Sonic Incytes

Active, not recruiting

The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF

Liver Fibroses | Non-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH) | Liver Steatoses

United States
Celgene

Terminated

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Liver Cirrhosis | Non-alcoholic Fatty Liver Disease

United States, Spain, Australia, Korea, Republic of, Canada, Germany, France, Japan, United Kingdom, Poland
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function

Alcoholism | Hepatic Cirrhosis

Germany, Belgium, United States, South Africa
Institute of Liver and Biliary Sciences, India

Unknown

Propofol for Sedation of Postoperative Electively Ventilated Liver Transplant Recipients.

Liver Cirrhoses

India
Fibronostics USA, Inc

Completed

Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.

Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Liver Inflammation | Liver Fibroses | Liver Steatoses

United States
Duke University

Terminated

BRIDGE Device for Post-operative Pain Control (BRIDGE)

Liver Diseases | Liver Failure | Pain, Postoperative | Liver Diseases, Alcoholic | Liver Cirrhosis, Biliary | Transplant; Failure, Liver

United States
Massachusetts General Hospital
Shriners

Recruiting

Developing Viability Index for Machine Perfused Livers

Liver Cirrhoses

United States

Clinical Trials on Alcoholic Liver Cirrhosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations